The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Raczynska, D.,
Ernest, J.,
Baumane, K.,
Sagong, M.,
Akiyama, K.,
Rauschning, W.,
Vajas, A.,
Nowosielska, A.,
Dusova, J.,
Majtánová, N.,
Oleksy, P.,
Kuneva, I.,
Resch, M. D.,
Lange, N.,
Briede, E.,
Bajdik, B.,
Jeong, A.,
Kozub, B.,
Papp, A.:
Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized).
Ophthalmol Ther. 15 (2), 887-899, 2026.
Vajas, A.,
Surányi, É.,
Balla, S.,
Nagy, D. L.,
Fodor, M.,
Nagy, A. C.,
Nagy, V.:
Color Doppler Ultrasound Assessment of Ophthalmic Artery-Derived Blood Flow in Non-Arteritic Anterior Ischaemic Optic Neuropathy.
Bratisl. Med. J. 127 (2), 814-820, 2025.
Balla, S.,
Vajas, A.,
Pásztor, O.,
Rentka, A.,
Lukucz, B.,
Kasza, M.,
Nagy, A. C.,
Fodor, M.,
Nagy, V.:
Analysis of the Association between Retinal Artery Occlusion and Acute Ischaemic Stroke/ST-Elevation Myocardial Infarction and Risk Factors in Hungarian Patients.
Medicina. 59 (9), 1-11, (article identifier: 1680), 2023.
Bressler, N. M.,
Veith, M.,
Hamouz, J.,
Ernest, J.,
Zalewski, D.,
Studnicka, J.,
Vajas, A.,
Papp, A.,
Vogt, G.,
Luu, J.,
Matuskova, V.,
Yoon, Y. H.,
Pregun, T.,
Kim, T.,
Shin, D.,
Oh, I.,
Jeong, H.,
Kim, M. Y.,
Woo, S. J.:
Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes.
Br. J. Ophthalmol. 107 (3), 384-391, 2023.
Woo, S. J.,
Sadda, S. R.,
Bradvica, M.,
Vajas, A.,
Sagong, M.,
Ernest, J.,
Studnicka, J.,
Veith, M.,
Wylegala, E.,
Patel, S.,
Yun, C.,
Orski, M.,
Astakhov, S.,
Tóth-Molnár, E.,
Csutak, A.,
Enyedi, L.,
Choi, W.,
Oh, I.,
Jang, H.:
Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial.
BMJ Open Ophth. 8 (1), 1-10, (article identifier: 001561), 2023.
Woo, S. J.,
Bradvica, M.,
Vajas, A.,
Sagong, M.,
Ernest, J.,
Studnicka, J.,
Veith, M.,
Wylegala, E.,
Patel, S.,
Yun, C.,
Orski, M.,
Astakhov, S.,
Tóth-Molnár, E.,
Csutak, A.,
Enyedi, L.,
Kim, T.,
Oh, I.,
Jang, H.,
Sadda, S. R.:
Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration.
JAMA Ophthalmol. 141 (7), 668-676, 2023.
Losonczy, G.,
Vajas, A.,
Takács, L.,
Dzsudzsák, E.,
Fekete, Á.,
Márhoffer, É.,
Kardos, L.,
Ajzner, É.,
Hurtado, B.,
de Frutos, P. G.,
Berta, A.,
Balogh, I.:
Effect of the Gas6 c.834+7G>A Polymorphism and the Interaction of Known Risk Factors on AMD Pathogenesis in Hungarian Patients.
PLoS One. 7 (11), e50181, 2012.
Petrovski, G.,
Berényi, E.,
Moe, M. C.,
Vajas, A.,
Fésüs, L.,
Berta, A.,
Facskó, A.:
Clearance of dying ARPE-19 cells by professional and nonprofessional phagocytes in vitro- implications for age-related macular degeneration (AMD).
Acta Ophthalmol. 89 (1), 30-34, 2011.
